Vol. 50 No. 3 (2011): Acta Oncologica

Articles

• Pediatric nasopharyngeal carcinoma treated with proton beam therapy. Two case reports

  Yoshiko Oshiro, Shinji Sugahara, Takashi Fukushima, Toshiyuki Okumura, Tomohei Nakao, Masashi Mizumoto, Takayuki Hashimoto, Koji Tsuboi, Michio Kaneko, Hideyuki Sakurai

  470-473

  Published: 2011-04-01

  • PDF

• Spatial density of primary malignant melanoma in sun-shielded body sites: A potential guide to melanoma genesis

  Boel K. Ragnarsson-Olding

  323-328

  Published: 2011-04-01

  • PDF

• HER2 status in operable breast cancers from Vietnamese women: Analysis by immunohistochemistry (IHC) and automated silver enhanced in situ hybridization (SISH)

  Vu Hong Thang, Edneia Tani, Ta Thanh Van, Kamilla Krawiec, Lambert Skoog

  360-366

  Published: 2011-04-01

  • PDF

• The impact of breast cancer on living an everyday life 4.5–5 years post-diagnosis – a qualitative prospective study of 39 women

  Pär Salander, Sara Lilliehorn, Katarina Hamberg, Anneli Kero

  399-407

  Published: 2011-04-01

  • PDF

• Diagnostic difficulties and delays with chest wall chondrosarcoma: A Swedish population based Scandinavian Sarcoma Group study of 106 patients

  Björn Widhe, Henrik C. F. Bauer

  435-440

  Published: 2011-04-01

  • PDF

• Neutropenic enterocolitis during first-line chemotherapy with carboplatin and etoposide in small cell lung cancer

  Louise Baandrup, Anders Hauggaard, Birgitte H. Winberg, Bente Holm

  465-467

  Published: 2011-04-01

  • PDF

• Use of interferon-alpha in two patients with Merkel cell carcinoma positive for Merkel cell polyomavirus

  Caroline Biver-Dalle, Thierry Nguyen, Antoine Touzé, Clarisse Saccomani, Séverine Penz, Sandrine Cunat-Peultier, Marie-Odile Riou-Gotta, Philippe Humbert, Pierre Coursaget, François Aubin

  479-480

  Published: 2011-04-01

  • PDF

• Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial

  Timo T. Purmonen, Emma Pänkäläinen, Juha H. O. Turunen, Christian Asseburg, Janne A. Martikainen

  344-352

  Published: 2011-04-01

• A comparative study of cancer patients with short and long sick-leave after primary treatment

  Sævar Berg Gudbergsson, Steffen Torp, Tone Fløtten, Sophie D. Fosså, Roy Nielsen, Alv A. Dahl

  381-389

  Published: 2011-04-01

  • PDF

• Impact of MRI in the management and staging of cancer of the uterine cervix

  Kristina Stenstedt, Ann-Cathrin Hellström, Susanne Fridsten, Lennart Blomqvist

  420-426

  Published: 2011-04-01

  • PDF

• Advanced aggressive fibromatosis: Effective palliation with chemotherapy

  Anastasia Constantinidou, Robin L. Jones, Michelle Scurr, Omar Al-Muderis, Ian Judson

  455-461

  Published: 2011-04-01

  • PDF

• Unusual discrepancy between CT and PET/CT in the initial staging of Hodgkin's lymphoma

  Fotios V. Michelis, Demitrios N. Exarhos, Ifigenia A. Tzannou, Themistoklis Karmiris, Emmanouil Nikiforakis

  474-476

  Published: 2011-04-01

  • PDF

• Dose-tailoring of FEC adjuvant chemotherapy based on leukopenia is feasible and well tolerated. Toxicity and dose intensity in the Scandinavian Breast Group phase 3 adjuvant Trial SBG 2000-1

  Per Edlund, Johan Ahlgren, Karsten Bjerre, Michael Andersson, Jonas Bergh, Henning Mouridsen, Stig B. Holmberg, Nils-Olof Bengtsson, Erik Jakobsen, Susanne Møller, Henrik Lindman, Carl Blomqvist

  329-337

  Published: 2011-04-01

  • PDF

• Reporting and incidence trends of hydatidiform mole in Sweden 1973–2004

  Sahar Salehi, Sandra Eloranta, Anna L.V. Johansson, Mats Bergström, Mats Lambe

  367-372

  Published: 2011-04-01

  • PDF

• Clinicians' use of guidelines as illustrated by curative treatment of prostate cancer at a comprehensive cancer center

  Andreas Stensvold, Alv A. Dahl, Sophie D. Fosså, Karol Axcrona, Wolfgang Lilleby, Bjørn Brennhovd, Sigbjørn Smeland

  408-414

  Published: 2011-04-01

  • PDF

• Clinical Phase I study with an Insulin-like Growth Factor-1 Receptor Inhibitor: Experiences in patients with squamous non-small cell lung carcinoma

  Simon Ekman, Jan-Erik Frödin, Johan Harmenberg, Antonina Bergman, Åsa Hedlund, Pia Dahg, Carina Alvfors, Birgitta Ståhl, Stefan Bergström, Michael Bergqvist

  441-447

  Published: 2011-04-01

  • PDF

• Giant phyllodes tumor of the breast: Consequence of carelessness

  Sonia Zayen, Habib Amouri, Mohamed Dhouib, Dalel Trigui, Belhassen Ben Ayed, Mohamed Guermazi

  468-470

  Published: 2011-04-01

  • PDF

• Cancer rehabilitation: A Nordic and European perspective

  Maria Hellbom, Corinna Bergelt, Mia Bergenmar, Brigitte Gijsen, Jon Håvard Loge, Matti Rautalathi

  179-186

  Published: 2011-04-01

  • PDF

• Difference in hormone receptor content in breast cancers from Vietnamese and Swedish women

  Vu Hong Thang, Edneia Tani, Hemming Johansson, Jan Adolfsson, Kamilla Krawiec, Ta Thanh Van, Lambert Skoog

  353-359

  Published: 2011-04-01

  • PDF

• Distress, quality of life, neuroticism and psychological coping are related in head and neck cancer patients during follow-up

  Anne K. H. Aarstad, Elisabeth Beisland, Arild André Osthus, Hans J. Aarstad

  390-398

  Published: 2011-04-01

  • PDF

• Magnetic resonance imaging of tumor necrosis

  Tormod A. M. Egeland, Jon-Vidar Gaustad, Kanthi Galappathi, Einar K. Rofstad

  427-434

  Published: 2011-04-01

  • PDF

• Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma

  Anna E. C. A. B. Willemsen, Carla M. L. van Herpen, Pieter Wesseling, Peter Bult, Hanneke W. M. van Laarhoven

  462-465

  Published: 2011-04-01

  • PDF

• Bilateral macular ischemia and severe visual loss following trastuzumab therapy

  Maher Saleh, Tristan Bourcier, Georges Noel, Claude Speeg-Schatz, David Gaucher

  477-478

  Published: 2011-04-01

  • PDF

• Tailored chemotherapy doses based on toxicity in breast cancer result in similar quality of life values, irrespective of given dose levels

  Mariann Iiristo, Tom Wiklund, Nils Wilking, Jonas Bergh, Yvonne Brandberg

  338-343

  Published: 2011-04-01

  • PDF

• Psychological resilience and long-term distress in Swedish and Icelandic parents’ adjustment to childhood cancer

  Eyglo Gudmundsdottir, Maria Schirren, Krister K. Boman

  373-380

  Published: 2011-04-01

  • PDF

• Standardized FDG uptake as a prognostic variable and as a predictor of incomplete cytoreduction in primary advanced ovarian cancer

  Signe Risum, Annika Loft, Claus Høgdall, Anne K. Berthelsen, Estrid Høgdall, Lene Lundvall, Lotte Nedergaard, Svend A. Engelholm

  415-419

  Published: 2011-04-01

  • PDF

• A Phase I–II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas

  Ulrik Lassen, Lars Henrik Jensen, Morten Sorensen, Kristoffer S. Rohrberg, Zaza Ujmajuridze, Anders Jakobsen

  448-454

  Published: 2011-04-01

  • PDF